Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1966
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1971 1
1972 1
1973 1
1974 1
1975 1
1976 1
1978 1
1979 1
1980 2
1981 3
1982 2
1983 2
1984 3
1985 3
1986 4
1987 10
1988 9
1989 13
1990 22
1991 15
1992 15
1993 30
1994 32
1995 31
1996 36
1997 49
1998 42
1999 41
2000 48
2001 51
2002 51
2003 51
2004 49
2005 53
2006 45
2007 35
2008 51
2009 41
2010 57
2011 53
2012 63
2013 72
2014 66
2015 83
2016 126
2017 126
2018 95
2019 72
2020 114
2021 136
2022 90
2023 75
2024 84
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,996 results

Results by year

Filters applied: . Clear all
Page 1
Guillain-Barre syndrome.
Shahrizaila N, Lehmann HC, Kuwabara S. Shahrizaila N, et al. Lancet. 2021 Mar 27;397(10280):1214-1228. doi: 10.1016/S0140-6736(21)00517-1. Epub 2021 Feb 26. Lancet. 2021. PMID: 33647239 Review.
Most patients with Guillain-Barre syndrome do well with immunotherapy, but a substantial proportion are left with disability, and death can occur. Results from the International Guillain-Barre Syndrome Outcome Study suggest that geographi …
Most patients with Guillain-Barre syndrome do well with immunotherapy, but a substantial proportion are left with disab …
Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis.
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. van den Berg B, et al. Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15. Nat Rev Neurol. 2014. PMID: 25023340 Review.
Guillain-Barre syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progressive, symmetrical weakness of the extremities. ...Molecular mimicry of pathogen-borne antigens, leading to generation of crossreactive antib
Guillain-Barre syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progres
Diagnosis and management of Guillain-Barre syndrome in ten steps.
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Leonhard SE, et al. Nat Rev Neurol. 2019 Nov;15(11):671-683. doi: 10.1038/s41582-019-0250-9. Epub 2019 Sep 20. Nat Rev Neurol. 2019. PMID: 31541214 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. ...
Guillain-Barre syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and ne
Guillain-Barre syndrome: a comprehensive review.
Bellanti R, Rinaldi S. Bellanti R, et al. Eur J Neurol. 2024 Aug;31(8):e16365. doi: 10.1111/ene.16365. Epub 2024 May 30. Eur J Neurol. 2024. PMID: 38813755 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is a potentially devastating yet treatable disorder. A classically postinfectious, immune-mediated, monophasic polyradiculoneuropathy, it is the leading global cause of acquired neuromuscular paralysis. ...
Guillain-Barre syndrome (GBS) is a potentially devastating yet treatable disorder. A classically postinfectious, immune
Guillain-Barre Syndrome in Children and Adolescents.
Langille MM. Langille MM. Adv Pediatr. 2023 Aug;70(1):91-103. doi: 10.1016/j.yapd.2023.04.001. Epub 2023 May 12. Adv Pediatr. 2023. PMID: 37422300 Review.
Guillain-Barre syndrome (GBS) is an immune-mediated disease of the peripheral nerves and cause of acute flaccid paralysis in children around the world. ...
Guillain-Barre syndrome (GBS) is an immune-mediated disease of the peripheral nerves and cause of acute flaccid paralys
Guillain-Barre syndrome: causes, immunopathogenic mechanisms and treatment.
Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Jasti AK, et al. Expert Rev Clin Immunol. 2016 Nov;12(11):1175-1189. doi: 10.1080/1744666X.2016.1193006. Epub 2016 Jun 21. Expert Rev Clin Immunol. 2016. PMID: 27292311 Free article. Review.
Guillain-Barre syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. ...Areas covered: In terms of etiology, Guillain-Barre s
Guillain-Barre syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of
Guillain-Barre syndrome and variants.
Dimachkie MM, Barohn RJ. Dimachkie MM, et al. Neurol Clin. 2013 May;31(2):491-510. doi: 10.1016/j.ncl.2013.01.005. Epub 2013 Feb 19. Neurol Clin. 2013. PMID: 23642721 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporeflexia or areflexia. ...
Guillain-Barre syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporefle
Diagnosis and treatment of Guillain-Barre Syndrome in childhood and adolescence: An evidence- and consensus-based guideline.
Korinthenberg R, Trollmann R, Felderhoff-Müser U, Bernert G, Hackenberg A, Hufnagel M, Pohl M, Hahn G, Mentzel HJ, Sommer C, Lambeck J, Mecher F, Hessenauer M, Winterholler C, Kempf U, Jacobs BC, Rostasy K, Müller-Felber W. Korinthenberg R, et al. Eur J Paediatr Neurol. 2020 Mar;25:5-16. doi: 10.1016/j.ejpn.2020.01.003. Epub 2020 Jan 7. Eur J Paediatr Neurol. 2020. PMID: 31941581 Review.
This evidence- and consensus-based practical guideline for the diagnosis and treatment of Guillain-Barre Syndrome (GBS) in childhood and adolescence has been developed by a group of delegates from relevant specialist societies and organisations; it is the res …
This evidence- and consensus-based practical guideline for the diagnosis and treatment of Guillain-Barre Syndrome (GBS) …
Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS).
van Doorn PA. van Doorn PA. Presse Med. 2013 Jun;42(6 Pt 2):e193-201. doi: 10.1016/j.lpm.2013.02.328. Epub 2013 Apr 28. Presse Med. 2013. PMID: 23628447 Review.
Guillain-Barre syndrome (GBS) is an acute polyneuropathy with a variable degree of weakness that reaches its maximal severity within 4 weeks. ...GBS can be subdivided in the acute inflammatory demyelinating polyneuropathy (AIDP), the most frequent form in the
Guillain-Barre syndrome (GBS) is an acute polyneuropathy with a variable degree of weakness that reaches its maximal se
Guillain-Barre syndrome.
Willison HJ, Jacobs BC, van Doorn PA. Willison HJ, et al. Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2. Lancet. 2016. PMID: 26948435 Review.
Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 100,000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barre syndrome are several recognisable var
Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 100,000 people develo
1,996 results